CatalystPit

RNAAtrium Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $8.28 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$141.63M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-22 · Younis Husam (Chief Scientific Officer) · OTHER
  • 2026-09-22 · Hoyos Rocio Martin (Chief Strategy Officer) · OTHER
  • 2026-09-22 · Boyce Sarah (Director) · OTHER
  • 2026-09-22 · Kenney Stephanie (See Remarks) · OTHER
  • 2026-09-22 · Gallagher Kathleen P. (See Remarks) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders156
Shares held14,470,521
Value$173.14M
Percent of shares outstanding84.60%
As of quarter end2026-06-30
RECENT NEWS
  • RNA: Atrium Therapeutics announces $50M offering
  • RNA: Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Atrium Therapeutics, Inc. (RNA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit